Abstract:Glioma remains to be an aggressive type of cancer with poor prognosis irrespective of the type of standard treatment applied. Therefore, identification of accurate early diagnostic methods and therapeutic strategies for glioma is imperative for the treatment of this disease. The expression of a number of miRNAs in glioma have been reported to be associated with the regulation of tumorigenic progression, cancer cell proliferation, metastasis, invasion, angiogenesis and drug resistance. The aim of the present study was to assess the function of the microRNA (miR/miRNA)-144-3p/BCL6 axis in glioma. Reverse transcription-quantitative PCR was used to measure miR-144-3p and BCL6 expression. Western blotting was used for measuring BCL6 expression. Luciferase reporter assay was used to assess the association between miR-144-3p and BCL6 and a tumor xenograft model was established for assess tumor growth. The data demonstrated that miR-144-3p was decreased whereas BCL6 expression was increased in glioma tissues compared with those in healthy human brain tissues, where miR-144-3p suppressed BCL6 expression by targeting the 3'-UTR sequence of BCL6. miR-144-3p overexpression alleviated proliferation and invasion in U251 cells whereas transfection with the BCL6-overexpressing plasmid rescued the suppressive effects of miR-144-3p upregulation on the proliferation and invasion of U251 cells. In addition, miR-144-3p overexpression and BCL6 downregulation inhibited tumor progression in a mouse tumor xenograft model. The present findings suggest that miR-144-3p and BCL6 may serve to be indicator of proliferation and invasion for patients with glioma. Furthermore, BCL6 may serve an important role in the miR-144-3p-mediated regulation of proliferation and invasion of glioma cells, where the miR-144-3p/BCL6 axis can be used to target patients with glioma therapeutically.

MicroRNA-365 Suppressed Cell Proliferation and Migration Via Targeting PAX6 in Glioblastoma.

Microrna-223 Promotes the Growth and Invasion of Glioblastoma Cells by Targeting Tumor Suppressor PAX6.

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MicroRNA-181 Inhibits Glioma Cell Proliferation by Targeting Cyclin B1.

MicroRNA-1179 Inhibits Glioblastoma Cell Proliferation and Cell Cycle Progression Via Directly Targeting E2F Transcription Factor 5.

MicroRNA-320 Inhibits Cell Proliferation in Glioma by Targeting E2F1

Upregulation of miR-144-3p expression attenuates glioma cell viability and invasion by targeting BCL6

MicroRNA-16 Inhibits Glioma Cell Growth and Invasion Through Suppression of BCL2 and the Nuclear Factor-Κb1/mmp9 Signaling Pathway.

Downregulation of Microrna-216B Contributes to Glioma Cell Growth and Migration by Promoting AEG-1-mediated Signaling.

PAX6, a Novel Target of Mir-335, Inhibits Cell Proliferation and Invasion in Glioma Cells

MicroRNA-16-5p Inhibits the Proliferation and Invasion of Glioma Cells by the Activation of P53/bax Signal Pathway

MicroRNA-338-5p Plays a Tumor Suppressor Role in Glioma Through Inhibition of the MAPK-signaling Pathway by Binding to FOXD1

Microrna-664 Regulates Cell Invasion And Migration And Epithelial-Mesenchymal Transition By Targeting Tgf-Beta Signal In Glioblastoma

MicroRNA-200b-3p Suppresses Epithelial-Mesenchymal Transition and Inhibits Tumor Growth of Glioma Through Down-Regulation of ERK5.

MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2.

MicroRNA-564 is Downregulated in Glioblastoma and Inhibited Proliferation and Invasion of Glioblastoma Cells by Targeting TGF-β1.

miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2

Down-regulation of miR-106b suppresses the growth of human glioma cells

Microrna-610 is Downregulated in Glioma Cells, and Inhibits Proliferation and Motility by Directly Targeting Mdm2

MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.